Pembrolizumab-induced fulminant triple M syndrome presenting with severe bradycardia
{{output}}
Immune checkpoint inhibitors have markedly transformed cancer treatment paradigms but are frequently associated with immune-related adverse events (irAEs) affecting multiple organ systems. Among the rare and severe complications is the "triple M syndrome", e... ...
